SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-070786
Filing Date
2024-08-19
Accepted
2024-08-19 17:17:42
Documents
54
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0211704-10q_anewmedi.htm   iXBRL 10-Q 514658
2 CERTIFICATION ea021170401ex31-1_anewmedi.htm EX-31.1 10915
3 CERTIFICATION ea021170401ex31-2_anewmedi.htm EX-31.2 13878
4 CERTIFICATION ea021170401ex32-1_anewmedi.htm EX-32.1 4175
5 CERTIFICATION ea021170401ex32-2_anewmedi.htm EX-32.2 4101
  Complete submission text file 0001213900-24-070786.txt   3692912

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE wena-20240630.xsd EX-101.SCH 35475
7 XBRL CALCULATION FILE wena-20240630_cal.xml EX-101.CAL 23545
8 XBRL DEFINITION FILE wena-20240630_def.xml EX-101.DEF 169341
9 XBRL LABEL FILE wena-20240630_lab.xml EX-101.LAB 304944
10 XBRL PRESENTATION FILE wena-20240630_pre.xml EX-101.PRE 168311
57 EXTRACTED XBRL INSTANCE DOCUMENT ea0211704-10q_anewmedi_htm.xml XML 417718
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
ANEW Medical, Inc. (Filer) CIK: 0001907223 (see all company filings)

IRS No.: 862727441 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41340 | Film No.: 241221670
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)